389 related articles for article (PubMed ID: 11748232)
21. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
22. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
Racek T; Mise N; Li Z; Stoll A; Pützer BM
J Biol Chem; 2005 Dec; 280(49):40402-5. PubMed ID: 16234237
[TBL] [Abstract][Full Text] [Related]
23. MDM2 and MDMX bind and stabilize the p53-related protein p73.
Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
Das S; El-Deiry WS; Somasundaram K
J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
[TBL] [Abstract][Full Text] [Related]
25. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
Dohn M; Zhang S; Chen X
Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
[TBL] [Abstract][Full Text] [Related]
26. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
27. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element.
Thornborrow EC; Manfredi JJ
J Biol Chem; 1999 Nov; 274(47):33747-56. PubMed ID: 10559267
[TBL] [Abstract][Full Text] [Related]
28. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.
Nakagawa T; Takahashi M; Ozaki T; Watanabe Ki K; Todo S; Mizuguchi H; Hayakawa T; Nakagawara A
Mol Cell Biol; 2002 Apr; 22(8):2575-85. PubMed ID: 11909952
[TBL] [Abstract][Full Text] [Related]
29. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
[TBL] [Abstract][Full Text] [Related]
30. TIP60 represses transcriptional activity of p73beta via an MDM2-bridged ternary complex.
Kim JW; Song PI; Jeong MH; An JH; Lee SY; Jang SM; Song KH; Armstrong CA; Choi KH
J Biol Chem; 2008 Jul; 283(29):20077-86. PubMed ID: 18499675
[TBL] [Abstract][Full Text] [Related]
31. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
32. DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest.
Vossio S; Palescandolo E; Pediconi N; Moretti F; Balsano C; Levrero M; Costanzo A
Oncogene; 2002 May; 21(23):3796-803. PubMed ID: 12032848
[TBL] [Abstract][Full Text] [Related]
33. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
34. Expression of the vascular endothelial growth factor gene is inhibited by p73.
Salimath B; Marmé D; Finkenzeller G
Oncogene; 2000 Jul; 19(31):3470-6. PubMed ID: 10918605
[TBL] [Abstract][Full Text] [Related]
35. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
[TBL] [Abstract][Full Text] [Related]
36. c-Jun regulates the stability and activity of the p53 homologue, p73.
Toh WH; Siddique MM; Boominathan L; Lin KW; Sabapathy K
J Biol Chem; 2004 Oct; 279(43):44713-22. PubMed ID: 15302867
[TBL] [Abstract][Full Text] [Related]
37. SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity.
Dai JM; Wang ZY; Sun DC; Lin RX; Wang SQ
J Cell Physiol; 2007 Jan; 210(1):161-6. PubMed ID: 16998810
[TBL] [Abstract][Full Text] [Related]
38. p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.
Momii Y; Izumi H; Shiota M; Onitsuka T; Abe T; Kobayashi H; Miyamoto N; Uchiumi T; Kohno K
Oncol Rep; 2007 Aug; 18(2):411-6. PubMed ID: 17611664
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
Kong XT; Gao H; Stanbridge EJ
J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer.
Naka M; Ozaki T; Takada N; Takahashi M; Shishikura T; Sakiyama S; Tada M; Todo S; Nakagawara A
Oncogene; 2001 Jun; 20(27):3568-72. PubMed ID: 11429704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
